Kerusso Capital Management’s AbbVie ABBV Stock Holding History

Kerusso Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.66M	Buy	22,511 +4,279	+23%	+$921K	2.06%	14
2026 Q1	$3.97M	Buy	18,232 +8,787	+93%	+$1.95M	1.99%	18
2025 Q4	$2.16M	Buy	9,445 +2,266	+32%	+$516K	1%	52
2025 Q3	$1.66M	Sell	7,179 -390	-5%	-$79.4K	1.02%	48
2025 Q2	$1.4M	Sell	7,569 -8,425	-53%	-$1.57M	0.87%	52
2025 Q1	$3.35M	Buy	15,994 +9,322	+140%	+$1.81M	2.13%	18
2024 Q4	$1.19M	Buy	6,672 +14	+0.2%	+$2.57K	0.76%	56
2024 Q3	$1.31M	Buy	6,658 +406	+6%	+$75.8K	0.84%	57
2024 Q2	$1.07M	Buy	+6,252	New	+$1.04M	0.78%	54

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Kerusso Capital Management's ABBV Position: Q2 2026 in Review

Kerusso Capital Management increased its AbbVie (ABBV) stake by 23% in Q2 2026, buying an estimated $921K and bringing the position to 22,511 shares worth $5.66M. The position accounts for 2.06% of the portfolio, ranked #14.

Kerusso Capital Management first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Kerusso Capital Management held 22,511 shares of AbbVie worth $5.66M as of Q2 2026.
Kerusso Capital Management bought 4,279 AbbVie shares in Q2 2026, an estimated $921K.
AbbVie made up 2.06% of Kerusso Capital Management's portfolio in Q2 2026, its #14 holding.
Kerusso Capital Management first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kerusso Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.